IRIX Shariah Compliance
Screening Methodology: AAOIFI
HALAL
Last Updated: April 03, 2026
Report Source: 2025 Annual Report
IRIDEX Corp. Stock Analysis IRIX
IRIDEX Corp. engages in developing, manufacturing, and marketing medical systems, delivery devices, and consumable instrumentation for the ophthalmology market. The company is headquartered in Mountain View, California and currently employs 93 full-time employees. The firm is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
Read More IRIDEX Corp (IRIX) Chart
Key Statistics of IRIDEX Corp (IRIX)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$1.02Volume
20.71KP/E Ratio (TTM)
-52 Week Range
Market Cap
18.27MAvg. Volume
56.98KDividend Yield
-Financial Metrics & Statements of IRIDEX Corp (IRIX)
FAQ's for IRIDEX Corp (IRIX)
- According to Musaffa’s Shariah screening methodology, IRIDEX Corp (IRIX) is currently classified as HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.